Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eboo Versi

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Urology|September 22, 2018
Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive BladderStefan De Wachter, Kevin D Benson, Roger R Dmochowski, et al.
The Journal of Urology|April 9, 2019
Re: Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive BladderStefan De Wachter, Kevin D Benson, Roger R Dmochowski, et al.
Neuropharmacology|December 4, 2017
DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's diseaseTom H Johnston, Eboo Versi, Patrick A Howson, et al.
Addiction Science & Clinical Practice|March 12, 2025
Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorderMatthew P Heshmatipour, Tyler M Duvernay, Desislava Z Hite, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Urology|September 22, 2018
Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive BladderStefan De Wachter, Kevin D Benson, Roger R Dmochowski, et al.
The Journal of Urology|April 9, 2019
Re: Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive BladderStefan De Wachter, Kevin D Benson, Roger R Dmochowski, et al.
Neuropharmacology|December 4, 2017
DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's diseaseTom H Johnston, Eboo Versi, Patrick A Howson, et al.
Addiction Science & Clinical Practice|March 12, 2025
Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorderMatthew P Heshmatipour, Tyler M Duvernay, Desislava Z Hite, et al.
Pageof 3